ES2183221T3 - INTRACELLULAR ADMINISTRATION THROUGH PRESSURE, MOLECULES OR MICROPARTICLES. - Google Patents
INTRACELLULAR ADMINISTRATION THROUGH PRESSURE, MOLECULES OR MICROPARTICLES.Info
- Publication number
- ES2183221T3 ES2183221T3 ES97948268T ES97948268T ES2183221T3 ES 2183221 T3 ES2183221 T3 ES 2183221T3 ES 97948268 T ES97948268 T ES 97948268T ES 97948268 T ES97948268 T ES 97948268T ES 2183221 T3 ES2183221 T3 ES 2183221T3
- Authority
- ES
- Spain
- Prior art keywords
- cell
- microparticles
- molecules
- pressure
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
- C12M3/04—Tissue, human, animal or plant cell, or virus culture apparatus with means providing thin layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/14—Bags
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
- C12M35/04—Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/40—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pressure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3517—Marker; Tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
Abstract
The invention provides a method of enhancing the uptake by a cell of an atom, a molecule, or particle of <10 mu m. The method involves (a) bringing into contact a cell and a liquid medium containing the atom, molecule, or particle, (b) maintaining the cell and the liquid medium in an enclosed space, and (c) subjecting the enclosed cell and liquid medium to an incubation pressure sufficient to enhance the uptake by the cell of the atom, molecule, or particle. <IMAGE>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/745,023 US5922687A (en) | 1995-05-04 | 1996-11-07 | Intracellular delivery of nucleic acids using pressure |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2183221T3 true ES2183221T3 (en) | 2003-03-16 |
Family
ID=24994918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97948268T Expired - Lifetime ES2183221T3 (en) | 1996-11-07 | 1997-11-07 | INTRACELLULAR ADMINISTRATION THROUGH PRESSURE, MOLECULES OR MICROPARTICLES. |
Country Status (16)
Country | Link |
---|---|
US (1) | US5922687A (en) |
EP (2) | EP1279412A3 (en) |
JP (3) | JP2001505419A (en) |
KR (1) | KR100449330B1 (en) |
CN (1) | CN1109749C (en) |
AT (1) | ATE223967T1 (en) |
AU (1) | AU736298B2 (en) |
BR (1) | BR9713334A (en) |
CA (1) | CA2271244C (en) |
DE (1) | DE69715449T2 (en) |
DK (1) | DK0944715T3 (en) |
ES (1) | ES2183221T3 (en) |
HK (1) | HK1022711A1 (en) |
IL (1) | IL129808A (en) |
PT (1) | PT944715E (en) |
WO (1) | WO1998020109A1 (en) |
Families Citing this family (132)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7803782B2 (en) * | 2003-05-28 | 2010-09-28 | Roche Madison Inc. | Intravenous delivery of polynucleotides to cells in mammalian limb |
US6627616B2 (en) * | 1995-12-13 | 2003-09-30 | Mirus Corporation | Intravascular delivery of non-viral nucleic acid |
US20020001574A1 (en) * | 1995-12-13 | 2002-01-03 | Jon A. Woiff | Process of delivering a polynucleotide to a muscle cell via the vascular system |
US7507722B1 (en) | 1999-11-05 | 2009-03-24 | Roche Madison Inc. | Intravascular delivery of nucleic acid |
US20040259828A1 (en) * | 1995-12-13 | 2004-12-23 | Wolff Jon A. | Intravascular delivery of non-viral nucleic acid |
US6379966B2 (en) * | 1999-02-26 | 2002-04-30 | Mirus Corporation | Intravascular delivery of non-viral nucleic acid |
US6676626B1 (en) | 1998-05-01 | 2004-01-13 | Ekos Corporation | Ultrasound assembly with increased efficacy |
US6582392B1 (en) | 1998-05-01 | 2003-06-24 | Ekos Corporation | Ultrasound assembly for use with a catheter |
US7435723B2 (en) * | 1997-11-21 | 2008-10-14 | Mirus Bio Corporation | Process for delivery of polynucleotides to the prostate |
US6699231B1 (en) | 1997-12-31 | 2004-03-02 | Heartport, Inc. | Methods and apparatus for perfusion of isolated tissue structure |
US6722370B1 (en) * | 1998-07-17 | 2004-04-20 | Corgentech, Inc. | Delivery of a composition to the liver by utilizing the portal vein |
WO2000015285A1 (en) * | 1998-09-14 | 2000-03-23 | Mirus Corporation | A process for delivering nucleic acids to cardiac tissue |
WO2000050617A1 (en) * | 1999-02-26 | 2000-08-31 | Mirus Corporation | Intravascular delivery of non-viral nucleic acid |
AU5771500A (en) * | 1999-06-28 | 2001-01-31 | Oklahoma Medical Research Foundation | Catalytically active recombinant memapsin and methods of use thereof |
ES2269199T3 (en) | 1999-11-05 | 2007-04-01 | Mirus Bio Corporation | INTRAVASCULAR SUPPLY OF NUCLEIC ACID. |
US7214369B2 (en) * | 2003-05-05 | 2007-05-08 | Mirus Bio Corporation | Devices and processes for distribution of genetic material to mammalian limb |
US7642248B2 (en) * | 1999-11-05 | 2010-01-05 | Roche Madison Inc | Devices and processes for distribution of genetic material to mammalian limb |
JP4776131B2 (en) | 1999-11-18 | 2011-09-21 | エピミューン インコーポレイテッド | Heteroclitic analogs and related methods |
US20040072785A1 (en) * | 1999-11-23 | 2004-04-15 | Wolff Jon A. | Intravascular delivery of non-viral nucleic acid |
US6346098B1 (en) | 2000-03-07 | 2002-02-12 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and kits for locally administering an active agent to an interstitial space of a host |
JP2003531865A (en) * | 2000-04-28 | 2003-10-28 | アメリカ合衆国 | Improving immunogenicity using a combination of DNA and vaccinia virus vector vaccines |
EP2075582A3 (en) | 2000-07-12 | 2010-01-06 | Agensys, Inc. | Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
WO2002008448A2 (en) * | 2000-07-25 | 2002-01-31 | The Board Of Trustees Of The Leland Stanford Junior University | Non-viral linear dna vectors and methods for using the same |
PT1313850E (en) | 2000-08-28 | 2008-11-18 | Agensys Inc | Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer |
AU2001298049A1 (en) | 2000-10-19 | 2003-05-19 | Epimmune Inc. | Hla class i and ii binding peptides and their uses |
AU2002306539A1 (en) * | 2001-02-16 | 2002-09-04 | The Board Of Trustees Of The Leland Stanford Junior University | Minimal plasmid vectors that provide for persistent and high level gene expression and methods for using the same |
US6924358B2 (en) | 2001-03-05 | 2005-08-02 | Agensys, Inc. | 121P1F1: a tissue specific protein highly expressed in various cancers |
US7271240B2 (en) | 2001-03-14 | 2007-09-18 | Agensys, Inc. | 125P5C8: a tissue specific protein highly expressed in various cancers |
US20030191073A1 (en) | 2001-11-07 | 2003-10-09 | Challita-Eid Pia M. | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
CA2443123A1 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
US10590418B2 (en) * | 2001-07-23 | 2020-03-17 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for RNAi mediated inhibition of gene expression in mammals |
CA2936534C (en) | 2001-07-23 | 2021-01-26 | The Board Of Trustees Of Leland Stanford Junior University | Methods and compositions for rnai mediated inhibition of gene expression in mammals |
AU2002336446B2 (en) | 2001-09-06 | 2008-03-06 | Agensys, Inc. | Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
EP1721977A3 (en) | 2001-09-17 | 2008-10-15 | PDL BioPharma, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
AU2002359576A1 (en) | 2001-12-03 | 2003-06-17 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US7141044B2 (en) * | 2001-12-11 | 2006-11-28 | Ekos Corporation | Alternate site gene therapy |
DE10211589A1 (en) * | 2002-03-15 | 2003-10-02 | Steffen-Sebastian Bolz | In vitro transfection and long-term cultivation of isolated organs |
US8226629B1 (en) | 2002-04-01 | 2012-07-24 | Ekos Corporation | Ultrasonic catheter power control |
US20030204167A1 (en) * | 2002-04-24 | 2003-10-30 | Johnson Lanny L. | Device for delivering liquid medications, nutrients or gases to local tissue |
US20060094006A1 (en) * | 2002-05-01 | 2006-05-04 | Genoveffa Franchini | Immunotherapy regimens in hiv-infected patients |
US20030228691A1 (en) * | 2002-05-17 | 2003-12-11 | Lewis David L. | Processes for inhibiting gene expression using polynucleotides |
JP4643255B2 (en) | 2002-06-10 | 2011-03-02 | バクシネックス インコーポレーティッド | Differentially expressed genes and encoded polypeptides in breast and bladder cancer |
US7589059B2 (en) * | 2002-07-26 | 2009-09-15 | Roche Madison Inc. | Delivery of molecules and complexes to mammalian cells in vivo |
US20040081653A1 (en) | 2002-08-16 | 2004-04-29 | Raitano Arthur B. | Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
EP2801614B1 (en) * | 2002-08-29 | 2019-05-15 | The Board of Trustees of the Leland Stanford Junior University | Circular nucleic acid vectors and methods for making and using the same |
US6921371B2 (en) | 2002-10-14 | 2005-07-26 | Ekos Corporation | Ultrasound radiating members for catheter |
JP2006508163A (en) | 2002-11-27 | 2006-03-09 | アジェンシス, インコーポレイテッド | Nucleic acids and corresponding proteins referred to as 24P4C12 useful in the treatment and detection of cancer |
EP1903056A3 (en) | 2002-12-10 | 2008-05-07 | Idm Pharma, Inc. | HLA-A1, -A2 -A3, -A24, -B7, and -B44 binding peptides comprising tumor associated antigen epitopes, and compositions thereof |
US7781415B2 (en) * | 2003-02-07 | 2010-08-24 | Roche Madison Inc. | Process for delivering sirna to cardiac muscle tissue |
EP2343315A3 (en) | 2003-02-10 | 2011-11-23 | Agensys, Inc. | Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
US20070037151A1 (en) * | 2003-04-28 | 2007-02-15 | Babe Lilia M | Cd4+ human papillomavirus (hpv) epitopes |
ATE541052T1 (en) | 2003-05-30 | 2012-01-15 | Agensys Inc | VARIANTS OF PROSTATE STEM CELL ANTIGEN (PSCA) AND PARTIAL SEQUENCES THEREOF |
CN1846000B (en) * | 2003-09-05 | 2012-10-03 | 金克克国际有限公司 | HPV CD8+ T-cell epitopes |
US20050164240A1 (en) * | 2003-10-06 | 2005-07-28 | Corgentech, Inc. | E2F oligonucleotide decoy molecules |
EP1709175A2 (en) * | 2003-12-03 | 2006-10-11 | Corgentech, Inc. | Hif oligonucleotide decoy molecules |
KR20060103957A (en) * | 2004-01-15 | 2006-10-04 | 알자 코포레이션 | Liposome composition for delivery of therapeutic agents |
GB0406728D0 (en) * | 2004-03-25 | 2004-04-28 | Hydrodynamic Gene Delivery Ltd | Gene therapy |
DK1747023T4 (en) | 2004-05-04 | 2016-05-02 | Univ Leland Stanford Junior | Methods and compositions for reducing the HCV viral genome amounts in a target cell |
US20050289659A1 (en) * | 2004-05-18 | 2005-12-29 | Jacks E T | Cre-lox based method for conditional RNA interference |
EP2583981A3 (en) | 2004-05-28 | 2013-07-31 | Agensys, Inc. | Antibodies and related molecules that bind to PSCA proteins |
US7482158B2 (en) * | 2004-07-01 | 2009-01-27 | Mathison Brian H | Composite polynucleic acid therapeutics |
TW200626724A (en) * | 2004-08-23 | 2006-08-01 | Paik Medicine International Inc | Method for gene transfer into the organelles of cells: direct gene transfer to mitochondria |
US20070036740A1 (en) * | 2004-10-06 | 2007-02-15 | Reed Kenneth C | Modulation of hair growth |
EP1807514A1 (en) * | 2004-10-22 | 2007-07-18 | Benitec, Inc. | Therapeutic rnai agents for treating psoriasis |
US20060115462A1 (en) * | 2004-12-01 | 2006-06-01 | Vladimir Subbotin | Direct DNA delivery to bone cells |
JP2008526229A (en) * | 2005-01-06 | 2008-07-24 | ベニテック,インコーポレーテッド | RNAi agents for stem cell maintenance |
ES2459466T3 (en) | 2005-02-25 | 2014-05-09 | Oncotherapy Science, Inc. | Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides |
DK2289533T3 (en) | 2005-02-28 | 2013-12-02 | Oncotherapy Science Inc | Epitope peptides derived from carendothelial growth factor receptor-1 as well as vaccines containing these peptides |
AU2006230563B8 (en) | 2005-03-31 | 2010-06-17 | Agensys, Inc. | Antibodies and related molecules that bind to 161P2F10B proteins |
US20060292159A1 (en) * | 2005-06-08 | 2006-12-28 | Ranscht Barbara E | Methods for the inhibition of neovascularization and cancer metastasis |
JP5095603B2 (en) | 2005-07-27 | 2012-12-12 | オンコセラピー・サイエンス株式会社 | Colon cancer-related gene TOM34 |
CA2618508A1 (en) * | 2005-08-10 | 2007-02-22 | Oklahoma Medical Research Foundation | Truncated memapsin 2 for use for treating alzheimer's disease |
US20070143195A1 (en) * | 2005-12-15 | 2007-06-21 | Bell Ryan B | Systems and methods for evaluating terms of a deal to purchase a vehicle |
US20070173470A1 (en) * | 2006-01-23 | 2007-07-26 | Chi-Hung Lin | Methods for delivering extracellular target into cells |
CN101568550B (en) | 2006-10-17 | 2012-12-26 | 肿瘤疗法科学股份有限公司 | Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
US10182833B2 (en) | 2007-01-08 | 2019-01-22 | Ekos Corporation | Power parameters for ultrasonic catheter |
TWI494319B (en) | 2007-02-21 | 2015-08-01 | Oncotherapy Science Inc | Peptide vaccines for cancers expressing tumor-associated antigens |
WO2008112226A2 (en) * | 2007-03-13 | 2008-09-18 | Massachusetts Institute Of Technology | Cre-lox based gene knockdown constructs and methods of use thereof |
TW201425333A (en) | 2007-04-11 | 2014-07-01 | Oncotherapy Science Inc | TEM8 peptides and vaccines comprising the same |
US8202983B2 (en) | 2007-05-10 | 2012-06-19 | Agilent Technologies, Inc. | Thiocarbon-protecting groups for RNA synthesis |
EP2494932B1 (en) | 2007-06-22 | 2020-05-20 | Ekos Corporation | Apparatus for treatment of intracranial hemorrhages |
US20100310640A1 (en) * | 2007-11-01 | 2010-12-09 | Knutson Keith L | Hla-dr binding peptides and their uses |
EP2612868B1 (en) | 2007-11-01 | 2018-08-15 | Astellas Pharma Inc. | Immunosuppressive polypeptides and nucleic acids |
EP2288379A4 (en) | 2008-05-19 | 2012-08-08 | Advaxis | Dual delivery system for heterologous antigens |
US9017660B2 (en) | 2009-11-11 | 2015-04-28 | Advaxis, Inc. | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors |
US9650639B2 (en) | 2008-05-19 | 2017-05-16 | Advaxis, Inc. | Dual delivery system for heterologous antigens |
JP5676436B2 (en) | 2008-06-17 | 2015-02-25 | ザ ガヴァーニング カウンシル オブ ザ ユニヴァーシティ オブ トロント | Device for investigation of flow conduits |
CA2728291C (en) * | 2008-07-03 | 2017-06-20 | The Board Of Trustees Of The Leland Stanford Junior University | Minicircle dna vector preparations and methods of making and using the same |
US8945885B2 (en) | 2008-07-03 | 2015-02-03 | The Board Of Trustees Of The Leland Stanford Junior University | Minicircle DNA vector preparations and methods of making and using the same |
JP5764822B2 (en) | 2008-08-27 | 2015-08-19 | オンコセラピー・サイエンス株式会社 | PRMT1 as a target gene for cancer treatment and diagnosis |
JP2012506858A (en) * | 2008-10-23 | 2012-03-22 | インターベット インターナショナル ベー. フェー. | Lawsonia intracellularis vaccine |
WO2010061881A1 (en) | 2008-11-26 | 2010-06-03 | 中外製薬株式会社 | Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus |
KR101727333B1 (en) | 2008-11-26 | 2017-04-14 | 추가이 세이야쿠 가부시키가이샤 | Vesicle preparation |
TWI500932B (en) | 2008-12-05 | 2015-09-21 | Oncotherapy Science Inc | Wdrpuh epitope peptides and vaccines containing the same |
TWI469791B (en) | 2009-02-18 | 2015-01-21 | Oncotherapy Science Inc | Foxm1 peptides and vaccines containing the same |
WO2010105135A1 (en) | 2009-03-13 | 2010-09-16 | Tufts University | Methods, apparatuses, and kits for introducing genetic material into living cells |
US9017991B2 (en) * | 2009-03-13 | 2015-04-28 | Tufts University | Methods tip assemblies and kits for introducing material into cells |
CN105601725B (en) | 2009-03-18 | 2019-08-09 | 肿瘤疗法科学股份有限公司 | NEIL3 peptide and vaccine comprising it |
TWI507204B (en) | 2009-05-26 | 2015-11-11 | Oncotherapy Science Inc | Cdc45l peptides and vaccines including the same |
US10016617B2 (en) | 2009-11-11 | 2018-07-10 | The Trustees Of The University Of Pennsylvania | Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers |
TW201136604A (en) | 2009-12-14 | 2011-11-01 | Oncotherapy Science Inc | TMEM22 peptides and vaccines including the same |
WO2011106705A2 (en) | 2010-02-26 | 2011-09-01 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Dna-protein vaccination protocols |
AU2011225577B2 (en) | 2010-03-11 | 2017-01-19 | Oncotherapy Science, Inc. | HJURP peptides and vaccines including the same |
US11020444B2 (en) * | 2010-04-23 | 2021-06-01 | Scicotec Gmbh | Transluminal delivery of viruses for treatment of diseased tissue |
EP2621527A4 (en) | 2010-10-01 | 2015-12-09 | Univ Pennsylvania | The use of listeria vaccine vectors to reverse vaccine unresponsiveness in parasitically infected individuals |
AU2012229218B2 (en) | 2011-03-11 | 2017-03-02 | Advaxis, Inc. | Listeria-based adjuvants |
UA113413C2 (en) | 2011-08-12 | 2017-01-25 | Онкотерапі Саєнс, Інк. | Mphosph1 peptides and vaccines including the same |
SG10201913173SA (en) | 2011-10-28 | 2020-03-30 | Oncotherapy Science Inc | Topk Peptides And Vaccines Including The Same |
BR112014022662A2 (en) | 2012-03-12 | 2017-10-03 | Advaxis Inc | INHIBITION OF SUPPRESSOR CELL FUNCTION FOLLOWING LISTERIA VACCINE TREATMENT |
JP6255594B2 (en) | 2012-07-10 | 2018-01-10 | オンコセラピー・サイエンス株式会社 | LY6K epitope peptide of Th1 cell and vaccine containing the same |
EP2872530A4 (en) | 2012-07-10 | 2016-04-06 | Oncotherapy Science Inc | Kif20a epitope peptides for th1 cells and vaccines containing the same |
AU2013317194B2 (en) | 2012-09-11 | 2018-07-12 | Oncotherapy Science, Inc. | UBE2T peptides and vaccines containing the same |
CA2895791A1 (en) | 2013-01-25 | 2014-07-31 | Xcell Biosciences, Inc. | Methods, compositions, kits, and systems for selective enrichment of target cells |
TWI658049B (en) | 2013-03-12 | 2019-05-01 | 腫瘤療法 科學股份有限公司 | Kntc2 peptides and vaccines containing the same |
US10982217B2 (en) | 2013-03-15 | 2021-04-20 | The Regents Of The University Of California | High-throughput cargo delivery into live cells using photothermal platforms |
ES2702622T3 (en) | 2013-03-27 | 2019-03-04 | Immunovaccine Technologies Inc | Method to improve the effectiveness of a survivin vaccine in the treatment of cancer |
CA2947539C (en) * | 2014-03-28 | 2022-10-04 | The Regents Of The University Of California | Efficient delivery of large cargos into cells on a porous substrate |
US10760040B1 (en) | 2014-07-03 | 2020-09-01 | NanoCav, LLC | Mechanical transfection devices and methods |
US10081816B1 (en) | 2014-07-03 | 2018-09-25 | Nant Holdings Ip, Llc | Mechanical transfection devices and methods |
ES2856834T3 (en) | 2014-08-04 | 2021-09-28 | Oncotherapy Science Inc | URLC10 derived peptide and vaccine containing the same |
JP6754958B2 (en) | 2014-08-04 | 2020-09-16 | オンコセラピー・サイエンス株式会社 | KOC1-derived peptide and vaccine containing it |
WO2016021508A1 (en) | 2014-08-04 | 2016-02-11 | オンコセラピー・サイエンス株式会社 | Cdca1-derived peptide and vaccine containing same |
JP2018509384A (en) | 2015-01-06 | 2018-04-05 | イミューノヴァクシーン テクノロジーズ インコーポレイテッドImmunovaccine Technologies Inc. | Lipid A mimics, methods of preparation, and uses thereof |
WO2016183420A1 (en) | 2015-05-13 | 2016-11-17 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Methods and compositions for inducing an immune response using conserved element constructs |
EP3307388B1 (en) | 2015-06-10 | 2022-06-22 | Ekos Corporation | Ultrasound catheter |
CA3000810A1 (en) | 2015-10-08 | 2017-04-13 | Oncotherapy Science, Inc. | Foxm1-derived peptide, and vaccine including same |
WO2017223199A1 (en) * | 2016-06-22 | 2017-12-28 | Xcell Biosciences, Inc. | Methods for increasing cell culture transfection efficiency and cellular reprogramming |
US10533189B2 (en) * | 2016-09-20 | 2020-01-14 | The Chinese University Of Hong Kong | Highly specific delivery of polynucleotides to the cell nucleus via compression |
CN111032134B (en) * | 2017-06-30 | 2024-02-13 | 阿维塔斯有限公司 | electrospray catheter |
TW202023581A (en) | 2018-08-02 | 2020-07-01 | 日商腫瘤療法 科學股份有限公司 | Cdca1-derived peptide and vaccine containing same |
AU2022299660A1 (en) * | 2021-06-24 | 2024-01-18 | Avectas Limited | Spray nozzle |
WO2023122797A1 (en) * | 2021-12-23 | 2023-06-29 | Intergalactic Therapeutics, Inc. | Devices and methods for hollow tissue electrotransfer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5698531A (en) * | 1989-03-31 | 1997-12-16 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
US5674192A (en) * | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
US5584803A (en) * | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
US5766901A (en) * | 1995-05-04 | 1998-06-16 | The Board Of Trustees Of The Leland Stanford Junior University | Apparatus and method for delivering a nucleotide into cell nuclei |
-
1996
- 1996-11-07 US US08/745,023 patent/US5922687A/en not_active Expired - Fee Related
-
1997
- 1997-11-07 CA CA002271244A patent/CA2271244C/en not_active Expired - Fee Related
- 1997-11-07 WO PCT/US1997/020696 patent/WO1998020109A1/en active IP Right Grant
- 1997-11-07 IL IL12980897A patent/IL129808A/en not_active IP Right Cessation
- 1997-11-07 CN CN97181265A patent/CN1109749C/en not_active Expired - Fee Related
- 1997-11-07 ES ES97948268T patent/ES2183221T3/en not_active Expired - Lifetime
- 1997-11-07 BR BR9713334-5A patent/BR9713334A/en not_active Application Discontinuation
- 1997-11-07 DE DE69715449T patent/DE69715449T2/en not_active Expired - Fee Related
- 1997-11-07 EP EP02019889A patent/EP1279412A3/en not_active Withdrawn
- 1997-11-07 AT AT97948268T patent/ATE223967T1/en not_active IP Right Cessation
- 1997-11-07 EP EP97948268A patent/EP0944715B1/en not_active Expired - Lifetime
- 1997-11-07 KR KR10-1999-7004103A patent/KR100449330B1/en not_active IP Right Cessation
- 1997-11-07 PT PT97948268T patent/PT944715E/en unknown
- 1997-11-07 JP JP52188198A patent/JP2001505419A/en not_active Withdrawn
- 1997-11-07 DK DK97948268T patent/DK0944715T3/en active
- 1997-11-07 AU AU70020/98A patent/AU736298B2/en not_active Ceased
-
2000
- 2000-03-17 HK HK00101643A patent/HK1022711A1/en not_active IP Right Cessation
-
2007
- 2007-09-04 JP JP2007228799A patent/JP2008054681A/en not_active Ceased
-
2008
- 2008-05-07 JP JP2008121322A patent/JP2008237221A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1279412A2 (en) | 2003-01-29 |
JP2001505419A (en) | 2001-04-24 |
KR20000053164A (en) | 2000-08-25 |
PT944715E (en) | 2003-01-31 |
EP0944715A1 (en) | 1999-09-29 |
AU7002098A (en) | 1998-05-29 |
KR100449330B1 (en) | 2004-09-18 |
BR9713334A (en) | 2000-05-09 |
AU736298B2 (en) | 2001-07-26 |
WO1998020109A1 (en) | 1998-05-14 |
EP1279412A3 (en) | 2003-12-17 |
EP0944715B1 (en) | 2002-09-11 |
CN1109749C (en) | 2003-05-28 |
JP2008237221A (en) | 2008-10-09 |
HK1022711A1 (en) | 2000-08-18 |
DK0944715T3 (en) | 2002-12-30 |
CA2271244A1 (en) | 1998-05-14 |
ATE223967T1 (en) | 2002-09-15 |
US5922687A (en) | 1999-07-13 |
IL129808A0 (en) | 2000-02-29 |
EP0944715A4 (en) | 1999-12-22 |
CN1244213A (en) | 2000-02-09 |
CA2271244C (en) | 2008-09-02 |
IL129808A (en) | 2004-06-20 |
JP2008054681A (en) | 2008-03-13 |
DE69715449D1 (en) | 2002-10-17 |
DE69715449T2 (en) | 2003-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2183221T3 (en) | INTRACELLULAR ADMINISTRATION THROUGH PRESSURE, MOLECULES OR MICROPARTICLES. | |
ATE218066T1 (en) | VACCINE CONTAINING NUCLEIC ACID | |
DE69616606T2 (en) | Polymer stabilization through a stable free radical | |
DE69114649D1 (en) | In-line gas / liquid dispersion. | |
ATE242317T1 (en) | METHOD FOR PURIFYING VIRUSES USING CHROMATOGRAPHY | |
GR3026658T3 (en) | Hydrazino-type radionuclide chelators having an n 3?s configuration | |
DK0593624T3 (en) | Improvements to or in relation to contrast agents | |
DE69938170D1 (en) | MIXING PROCESS | |
SE9801287D0 (en) | Incorporation of active substances into carrier matrixes | |
EP1158320A3 (en) | Dichroic light polarizers | |
DE69024002D1 (en) | Device for coding two-dimensional information and corresponding decoding device. | |
ZA966118B (en) | Interseparation of platinum group metals. | |
NZ305188A (en) | DNA encoding Human Papilloma Virus (hPV)type 18 | |
NO931689D0 (en) | DEVICE FOR ELECTROCHEMICAL SYNTHESIS FOR "IN-LINE" AND "OFF-LINE", WHEATING, OXIDATION AND DISINFECTION OF ORGANIC SUBSTANCES IN LIQUID. | |
ATE209486T1 (en) | LIQUID MEDICINAL COMPOSITIONS CONTAINING IBUPROFEN | |
Evans | Front Cover-" But now, I am found" | |
KR920004281A (en) | Solid-Liquid Separation and Concentration Methods in Wastewater Treatment | |
RU96108731A (en) | METHOD FOR PRODUCING FIRE-PROTECTED CHEMICAL FIBERS | |
Occulto | Writing in the biology classroom | |
ES2120916A1 (en) | Instrument for qualifying the mechanical preservation status of biological surfaces | |
Scheidt | Teacher immediacy and student communication apprehension in the college classroom | |
Sawvel | Analysis of immunogenicity of cellular envelope proteins (CEP) isolated from Pseudomonas aeruginosa | |
UA29496C2 (en) | rotor for mixing devices | |
Tobias | Reading Trends | |
Abou Jaoude | Plastic analysis of rigid frames using micro computer graphics |